More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases

Generic Pharmaceuticals Price Fixing
Antitrust, Health Care, Healthcare
Lowey Dannenberg represents 34 of the nation’s largest health insurers, including Elevance Health (formerly known as Anthem), Aetna, Humana, and 25 BlueCross BlueShield licensees in connection with their claims relating […]

Swiss Franc LIBOR
Antitrust
Lowey Dannenberg is the court-appointed sole lead counsel in a class action against numerous global financial institutions responsible for setting the London Interbank Offered Rate for the Swiss Franc (Swiss […]

Euribor
Antitrust
Lowey Dannenberg is leading the prosecution against the global financial institutions responsible for the setting of the Euro Interbank Offered Rate (“Euribor”), a global reference rate used to benchmark, price […]
News
Lowey Wins Preliminary Approval of Ranbaxy Purchasers’ $145M Settlement
On April 28, 2022 U.S. District Court Judge Nathanial M. Gorton in the District of Massachusetts preliminarily approved one of the largest pharmaceutical antitrust settlements ever recovered on behalf of classes of end-payors. The proposed settlement provides for the…
Blog
SEC to Attorneys: Help Register Cryptocurrencies Instead of Advising on How to Skirt Securities Laws
On November 4, 2021, U.S. Securities and Exchange Commission (“SEC”) Chairman Gary Gensler spoke at the Securities Enforcement Forum. While Gensler spoke on a variety of topics related to the agency’s enforcement mission, his remarks on cryptocurrencies, particularly as they relate to attorneys,…





